Watch: Trump to announce Medicaid drug pricing plan

President Trump used remarks on Friday to present a new step in his administration's efforts to lower prescription drug costs. The announcement centered on expanding access to "most favored nation" pricing for certain medicines through state Medicaid programs. According to the administration, the policy change will extend access to this pricing approach to Medicaid programs in all 50 states. The move was portrayed as part of broader efforts by the administration to reduce the price of prescription drugs, though specifics on which drugs would be covered or how the policy would be implemented were not detailed in the remarks provided. Trump delivered the announcement alongside Health and Human Services Secretary Robert F. Kennedy Jr. and other members of his administration. The presentation followed prior administration initiatives aimed at addressing drug pricing, positioning this change as an additional measure in that ongoing policy focus. At the event, officials emphasized the administration's intent to make prescription drugs more affordable through federal policy changes. Further details, including implementation timelines and the scope of drugs affected, were not included in the portion of the remarks summarized here.